9th Annual Biomarkers Congress
Collaborative Innovation in Biomedicine
Marriott at Metro Center
775 12th Street NW
xx, Washington DC
http://www.healthtech.com/Conferences_Overview.aspx?id=88964
Collaborative Innovation in Biomedicine
Cambridge Healthtech Institute
 Marriott at Metro Center

Schedule of Presentations:

Monday, June 22, 2009
07:30:00 Registration and Morning Coffee
07:35:00 Morning Session
08:30:00 Conference Introduction
08:45:00 The Power of Collaborative Innovation and the Architecture of Trust Robert Porter
09:15:00 Defining Characteristics of Successful Models of Collaborative Innovation William B. Mattes
09:45:00 Revising the Role of Intellectual Property - From Exclusivity to Partnership Richard Gold
10:15:00 Information Flows and IP Control in Pre-Competitive Collaborations Mark Anthony Mersereau
10:45:00 Networking Coffee Break
11:10:00 “Radical Collaboration” – How IBM Transformed the Semiconductor Industry through Pre-Competitive Collaborative Innovation – A Hi-Tech Industry Case Study Bernard Meyerson
11:45:00 How Collaborative Innovation Aids the Regulatory Process and Vice-Versa Bruno Flamion
12:00:00 Overcoming Resistance to Sharing Drug Safety Results Arthur L Holden
12:15:00 Lunch on Your Own
12:20:00 Afternoon Session FACILITATING DATA SHARING
13:45:00 Chairperson’s Remarks
13:50:00 Keynote Address Keynote Address Speeding Research and Development through a Collaborative Ecosystem Ken Buetow
14:25:00 Taking a Pre-Competitive Approach to Defining Standards and Leveraging Best Practices to Enable Basic Research Collaboration Martin D. Leach
14:55:00 Gaining Efficiencies through Open Innovation Susie Stephens
15:25:00 Networking Refreshment Break
16:00:00 Customer Perspective on Pre-Competitive Software Development (tentative)
16:30:00 The Value of and Standards for Facilitated Data Sharing- Collaborative Activities in Research and Healthcare Jessica J. Nadler, Rebecca Kush
17:00:00 Breakout Round-Table Discussions
17:05:00 Issues of Shared IP from Consortia Research Richard Gold
17:10:00 Solutions for Facilitating Data Sharing in Collaborative Research Martin D. Leach
17:20:00 Governance, Organizational Management and Trust Building Issues for Consortia Robert Porter
17:25:00 Shared Development of Tools and Technology Catherine Oyler, Erik Kuja
17:30:00 Working to Enable Regulatory Changes Bruno Flamion
17:35:00 Information Infrastructure for Collaborative Therapy Development Jay Tenenbaum
18:00:00 Networking Reception
19:00:00 End of Day One
Tuesday, June 23, 2009
07:30:00 Morning Session Dagmar Ringe, Raymond C. Stevens, Paul Labute, Micah Lieberman
08:00:00 Chairperson’s Remarks
08:05:00 Round-Table Reports
08:10:00 CONSORTIA CASE STUDIES
08:45:00 The Innovative Medicines Initiative: Driving a New Paradigm in Pre-Competitive Research Jackie Hunter
09:15:00 Successes and Renewal of the Dundee Signaling Consortium Malcolm M. Skingle
09:45:00 Where No One Has Gone Before – A Collaborative Model to De-risk Discovery and Development of First-in-Class Therapies (How Non-Profits can use their Mission to be a Unique Convener of Pre-Competitive Collaborations) Rusty Bromley
09:45:00 Where No One Has Gone Before – A Collaborative Model to De-risk Discovery and Development of First-in-Class Therapies (How Non-Profits can use their Mission to be a Unique Convener of Pre-Competitive Collaborations) Rusty Bromley
10:15:00 Enlight Biosciences and Related Examples: Pre-competitive Collaboration to Ensure Development and Acceptance of Critical New Technology Erik Kuja
10:55:00 Networking Coffee Break
11:00:00 DRUG SAFETY CONSORTIA
11:30:00 The Serious Adverse Event Consortium, Ltd. [SAEC] — Formation and Current Status of an International Effort to Understand the Genetic Basis of Drug Related Serious Adverse Events Arthur L Holden
12:00:00 The Drug Safety Executive Council (DSEC) Efforts in Collaborative Drug Safety Evaluation Ernie Bush
12:30:00 Luncheon Presentation Health Commons: An e-Business Approach to Collaborative Therapy Development Jay Tenenbaum
12:35:00 Afternoon Session
12:40:00 CONSORTIA CASE STUDIES (Continued) BIOMARKER CONSORTIA
14:10:00 Chairperson’s Remarks
14:15:00 HESI’s Experience in Collaborative Approaches to Science Syril D. Pettit
14:45:00 The Biomarkers Consortium David Wholley
15:15:00 The Predictive Safety Testing Consortium: Advancing Translational Toxicology through Inter-disciplinary and Inter-organizational Collaboration Elizabeth Gribble Walker
15:45:00 The Future of Pre-Competitive Consortia – A Best Practices Panel Discussion Jackie Hunter, Martin D. Leach, Arthur L Holden, Jay Tenenbaum, William B. Mattes
17:00:00 Close of Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.